RxDoctor Payments Data

Megan Coylewright

Interventional Cardiology · Calhoun, GANPI 1003961772

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 68.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $132,290 and has fallen 56.6% since, to $57,355 in 2025. Among interventional cardiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$270,788in general payments, 2019–2025

Across 374 payments — averaging $724.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$186K
  • Edwards Lifesciences$59K
  • Medtronic$16K
  • Abbott$4K
  • Recor Medical Inc$3K
  • W. L. Gore & Associates, Inc.$1K
  • plus $1K from 12 others
$2,062,527in research payments, 2019–2025

Across 183 payments — averaging $11,271 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$1.2M
  • Boston Scientific$552K
  • Medtronic$207K
  • Abbott$69K
  • Recor Medical Inc$3K

What the payments were for

  • Consulting fees$87,56332%
  • Speaking & faculty fees$145,39454%
  • Grants$7850%
  • Travel & lodging$22,6668%
  • Food & beverage$14,3815%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$270,788 in reported general payments places this provider in the 95th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate12$158
Amlodipine Besylate15$43

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Calhoun

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →